Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis

Journal of General Virology

Volumn 81, Issue 2, 2000, Pages 317-325

  Van Duin, Mark ^a   Snijders, Peter J F ^a   Vossen, Mireille T M ^a   Klaassen, Erik ^a   Voorhorst, Feja ^a   Verheijen, René H M ^a   Heimerhorst, Theo J ^b   Meijer, Chris J L M ^a   Walboomers, Jan M M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CODON; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NETHERLANDS; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPOVAVIRIDAE;

EID: 0033979712     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-2-317     Document Type: Article

References (34)

1. Beckman, G., Birgander, R., Själander, A., Saha, N., Holmberg, P. A., Kivelä, A. & Beckman, L. (1994). Is p53 polymorphism maintained by natural selection? Human Heredity 44, 266-270.
2. Bontkes, H. J., Van Duin, M., DeGruijl, T. D., Duggan-Keen, M. F., Walboomers, J. M. M., Stukart, M. J., Verheijen, R. H. M., Heimerhorst, T. J. M., Meijer, C. J. L. M., Seheper, R. J., Stevens, F. R. A., Dyer, P. A., Sinnott, P. & Stern, P. L. (1998). HPV-16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV-16 E6 sequence variants. International Journal of Cancer 78, 166-171.
3. Conrad Stöppler, M., Ching, K., Stöppler, H., Clancy, K., Schlegel, R. & Icenogle, J. P. (1996). Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation, Journal of Virology 70, 6987-6993.
4. de Roda Husman, A.-M., Walboomers, J. M. M., van den Brule, A. J. C, Meijer, C. J. L. M. & Snijders, P. J. F. (1995). The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. Journal of General Virology 76, 1057-1062.
5. Giannoudis, A., Graham, D. A., Southern, S. A. & Herrington, C. S. (1999). The p53 codon 72 Arg/Pro polymorphism is not related to HPV type or lesion grade in low and high grade squamous intraepithelial lesions and invasive squamous carcinoma of the cervix. International Journal of Cancer 83, 66-69.
6. Hayes, V. M., Hofstra, R. M. W., Buys, C. H. C. M., Hollema, H. & Van Der Zee, A. G. J. (1998). Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet 352, 1756.
7. Helland, A., Langerod, A., Johnsen, H., Olsen, A. O., Skovlund, E. & Borresen-Dale, A. L. (1998). p53 polymorphism and risk of cervical cancer. Nature 396, 530-531.
8. Hildesheim, A., Schiffman, M., Brinton, L. A., Fraumeni, J. F., Herrero, R., Bratti, M. C, Schwartz, P., Mortel, R., Barnes, W., Greenberg, M., McGowan, L., Scott, D. R., Martin, M., Herrera, J. E. & Carrington, M. (1998). p53 polymorphism and risk of cervical cancer. Nature 396, 531-532.
9. Hultman, T., Bergh, S., Moks, T. & Uhlen, M. (1991 ). Bidirectional solid phase sequencing of in vitro amplified plasmid DNA. BioTechniques 10, 84-93.
10. IARC (1995). IARC monographs on the evaluation of the carcinogenic risks to humans. Lyon, France: IARC Scientific Publications.
11. Jacobs, M. V., De Roda Husman, A. M., Van Den Brule, A. J. C., Snijders, P. J. F., Meijer, C. J. L. M. & Walboomers, J. M. M. (1995). Group-specific differentiation between high and low risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. Journal of Clinical Microbiology 33, 901-905.
12. Josefsson, A. M., Magnusson, P. K. E., Ylitalo, N., Quarforth-Tubbin, P., Ponten, J., Adami, H. O. & Gyllensten, U. B. (1998). p53 polymorphism and risk of cervical cancer. Nature 396, 531.
13. Klaes, R., Ridder, R., Schaefer, U., Benner, A. & Doeberitz, M. V. (1999). No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer. Journal of Molecular Medicine 77, 299-302.
14. Lanham, S., Campbell, I., Watt, P. & Gornall, R. (1998). p53 polymorphism and risk of cervical cancer. Lancet 352, 1631.
15. Londesborough, P., Ho, L, Terry, G., Cuzick, J., Wheeler, C. & Singer, A. (1996). Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. International Journal of Cancer 69, 364-368.
16. Minaguchi, T., Kanamori, Y., Matsushima, M., Yoshikawa, H., Taketani, Y. & Nakamura, Y. (1998). No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Research 58, 4585-4586.
17. Mullokandov, M. R., Kholodilov, N. G., Atkin, N. B., Burk, R. D., Johnson, A. B. & Klinger, H. P. (1996). Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papillomavirus tumor status. Cancer Research 56, 197-205.
18. Myers, G., Delius, H., lcenogle, J. P., Bernard, H. U., Baker, C., Halpern, A. & Wheeler, C. (1995). HPV and animal PV nucleic acid sequences. In Human Papillomavirus Compendium. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos, NM : Los Alamos National Laboratory.
19. Nindl, I., Rindfleisch, K., Lotz, B., Schneider, A. & Dürst, M. (1999). Uniform distribution of HPV-16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. International Journal of Cancer 82, 203-207.
20. Nobbenhuis, M. A. E., Walboomers, J. M. M., Helmerhorst, T. H. J. M., Rozendaal, L, Remmink, A. J., Risse, E. K. J., van der Linden, H. C., Voorhorst, F. J., Kenemans, P. & Meijer, C. J. L. M. (1999). Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 354, 20-25.
21. Remmink, A. J., Walboomers, J. M. M., Heimerhorst, T. H. J. M., Voorhorst, F. J., Rozendaal, L., Risse, E. K. J., Meijer, C. J. L. M. & Kenemans, P. (1995). The presence of persistent high-risk HPV genotypes is associated with progressive disease : natural history up to 36 months. International Journal of Cancer 61, 306-311.
22. Rosenthal, A. N., Ryan, A., Al-Jehani, R. M., Storey, A., Harwood, C. A. & Jacobs, I. J. (1998). p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 352, 871-872.
23. Sang Song, Y., Kee, H. S., Kim, J. W., Park, N. H., Kang, S. B., Chang, W. H. & Lee, H. P. (1997). Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecologic Oncology 66, 275-281.
24. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. (1990). The E6 oncoprotein encoded by the human papillomavirus type 16 and 18 promotes degradation of p53. Cell 63, 1129-1136.
25. Snijders, P. J. F., Van Duin, M., Walboomers, J. M. M., Steenbergen, R. D. M., Risse, E. K. J., Helmerhorst, T. J. M., Verheijen, R. H. M. & Meijer, C. J. L. M. (1998). Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Research 58, 3812-3818.
26. Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G. & Banks, L. (1998). Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393, 229-234.
27. Van Ranst, M. A., Tachezy, R., Delius, H. & Burk, R. D. (1993). Taxonomy of the human papillomaviruses. Papillomavirus Reports 4, 61-65.
28. Walboomers, J. M. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., Snijders, P. J. F., Peto, J., Meijer, C. J. L M. & Munoz, N. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology 189, 12-19.
29. Werness, B. A., Levine, A. J. & Howley, P. M. (1990). Association of human papillomavirus type 16 and 18 E6 proteins with p53. Science 248, 76-79.
30. Xi, L. F., Koutsky, L. A., Galloway, D. A., Kuypers, J., Hughes, J. P., Wheeler, C. M., Holmes, K. K. & Kiviat, N. B. (1997). Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. Journal of the National Cancer Institute 89, 796-802.
31. Yamada, T., Manos, M. M., Peto, J., Greer, C. E., Munoz, N., Bosch, F. X. & Wheeler, C. M. (1997). Human papillomavirus type 16 sequence variation in cervical cancers : a worldwide perspective. Journal of Virology 71, 2463-2472.
32. Zehbe, I., Voglino, G., Delius, H., Wilander, E. & Tommasino, M. (1998a). Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352, 1441-1442.
33. Zehbe, I., Wilander, E., Delius, H. & Tommasino, M. (1998b). Human papillomavirus 16 E6 variants are more prevalent in invasive cervical cancer than the prototype. Cancer Research 58, 829-833.
34. Zehbe, I., Voglino, G., Wilander, E., Genta, F. & Tommasino, M. (1999). Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 354, 218-219.